Zobrazeno 1 - 10
of 84
pro vyhledávání: '"Maria Carmona Iragui"'
Autor:
Bessy Benejam, Mateus Rozalem Aranha, Laura Videla, Concepción Padilla, Silvia Valldeneu, Susana Fernández, Miren Altuna, Maria Carmona-Iragui, Isabel Barroeta, Maria Florencia Iulita, Víctor Montal, Jordi Pegueroles, Alexandre Bejanin, Sandra Giménez, Sofía González-Ortiz, Sebastián Videla, David Bartrés-Faz, Daniel Alcolea, Rafael Blesa, Alberto Lleó, Juan Fortea
Publikováno v:
Alzheimer’s Research & Therapy, Vol 14, Iss 1, Pp 1-10 (2022)
Abstract Background Adults with Down syndrome are at an ultra-high risk of developing early-onset Alzheimer’s disease. Episodic memory deficits are one of the earliest signs of the disease, but their association with regional brain atrophy in the p
Externí odkaz:
https://doaj.org/article/bb83f1f0007549a38acaf11efccf2f77
Autor:
Nuole Zhu, Miguel Santos-Santos, Ignacio Illán-Gala, Victor Montal, Teresa Estellés, Isabel Barroeta, Miren Altuna, Javier Arranz, Laia Muñoz, Olivia Belbin, Isabel Sala, Maria Belén Sánchez-Saudinós, Andrea Subirana, Laura Videla, Jordi Pegueroles, Rafael Blesa, Jordi Clarimón, Maria Carmona-Iragui, Juan Fortea, Alberto Lleó, Daniel Alcolea
Publikováno v:
Translational Neurodegeneration, Vol 10, Iss 1, Pp 1-12 (2021)
Abstract Background Astrocytes play an essential role in neuroinflammation and are involved in the pathogenesis of neurodenegerative diseases. Studies of glial fibrillary acidic protein (GFAP), an astrocytic damage marker, may help advance our unders
Externí odkaz:
https://doaj.org/article/6687482bcff54ddc98db373982187b7c
Autor:
Alberto Lleó, Maria Carmona-Iragui, Laura Videla, Susana Fernández, Bessy Benejam, Jordi Pegueroles, Isabel Barroeta, Miren Altuna, Silvia Valldeneu, Mei-Fang Xiao, Desheng Xu, Raúl Núñez-Llaves, Marta Querol-Vilaseca, Sònia Sirisi, Alexandre Bejanin, M. Florencia Iulita, Jordi Clarimón, Rafael Blesa, Paul Worley, Daniel Alcolea, Juan Fortea, Olivia Belbin
Publikováno v:
Alzheimer’s Research & Therapy, Vol 13, Iss 1, Pp 1-10 (2021)
Abstract Background There is an urgent need for objective markers of Alzheimer’s disease (AD)-related cognitive impairment in people with Down syndrome (DS) to improve diagnosis, monitor disease progression, and assess response to disease-modifying
Externí odkaz:
https://doaj.org/article/847ead8ea91e4a79b59f578b40be03af
Autor:
Nuole Zhu, Miguel Santos-Santos, Ignacio Illán-Gala, Victor Montal, Teresa Estellés, Isabel Barroeta, Miren Altuna, Javier Arranz, Laia Muñoz, Olivia Belbin, Isabel Sala, Maria Belén Sánchez-Saudinós, Andrea Subirana, Laura Videla, Jordi Pegueroles, Rafael Blesa, Jordi Clarimón, Maria Carmona-Iragui, Juan Fortea, Alberto Lleó, Daniel Alcolea
Publikováno v:
Translational Neurodegeneration, Vol 12, Iss 1, Pp 1-1 (2023)
Externí odkaz:
https://doaj.org/article/728bf5fcfa3647ed8c62bb27654cb487
Autor:
Olivia Belbin, Mei-Fang Xiao, Desheng Xu, Maria Carmona-Iragui, Jordi Pegueroles, Bessy Benejam, Laura Videla, Susana Fernández, Isabel Barroeta, Raúl Nuñez-Llaves, Victor Montal, Eduard Vilaplana, Miren Altuna, Jordi Clarimón, Daniel Alcolea, Rafael Blesa, Alberto Lleó, Paul F. Worley, Juan Fortea
Publikováno v:
Molecular Neurodegeneration, Vol 15, Iss 1, Pp 1-10 (2020)
Abstract Background Alzheimer’s disease (AD) is the major cause of death in adults with Down syndrome (DS). There is an urgent need for objective markers of AD in the DS population to improve early diagnosis and monitor disease progression. NPTX2 h
Externí odkaz:
https://doaj.org/article/0c1c43d3ccb644e492a07268b4f71135
Autor:
Manon Moreau, Maria Carmona-Iragui, Miren Altuna, Lorraine Dalzon, Isabel Barroeta, Marie Vilaire, Sophie Durand, Juan Fortea, Anne-Sophie Rebillat, Nathalie Janel
Publikováno v:
Biomedicines, Vol 10, Iss 6, p 1380 (2022)
Down syndrome (DS) is a complex genetic condition due to an additional copy of human chromosome 21, which results in the deregulation of many genes. In addition to the intellectual disability associated with DS, adults with DS also have an ultrahigh
Externí odkaz:
https://doaj.org/article/a1e8ccb6ce1d43aa85966d7f9b2a96f9
Autor:
Anke Hüls, Alberto C.S. Costa, Mara Dierssen, R. Asaad Baksh, Stefania Bargagna, Nicole T. Baumer, Ana Claudia Brandão, Angelo Carfi, Maria Carmona-Iragui, Brian Allen Chicoine, Sujay Ghosh, Monica Lakhanpaul, Coral Manso, Miguel-Angel Mayer, Maria del Carmen Ortega, Diego Real de Asua, Anne-Sophie Rebillat, Lauren Ashley Russell, Giuseppina Sgandurra, Diletta Valentini, Stephanie L. Sherman, Andre Strydom
Publikováno v:
EClinicalMedicine, Vol 33, Iss , Pp 100769- (2021)
Background: Health conditions, immune dysfunction, and premature aging associated with trisomy 21 (Down syndrome, DS) may impact the clinical course of COVID-19. Methods: The T21RS COVID-19 Initiative launched an international survey for clinicians o
Externí odkaz:
https://doaj.org/article/9c25be214b9744a8ba1cb6dcf20d9d05
Autor:
Bessy Benejam, Laura Videla, Eduard Vilaplana, Isabel Barroeta, Maria Carmona‐Iragui, Miren Altuna, Silvia Valldeneu, Susana Fernandez, Sandra Giménez, Florencia Iulita, Diana Garzón, Alexandre Bejanin, David Bartrés‐Faz, Sebastià Videla, Daniel Alcolea, Rafael Blesa, Alberto Lleó, Juan Fortea
Publikováno v:
Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring, Vol 12, Iss 1, Pp n/a-n/a (2020)
Abstract Introduction We aimed to define prodromal Alzheimer's disease (AD) and AD dementia using normative neuropsychological data in a large population‐based cohort of adults with Down syndrome (DS). Methods Cross‐sectional study. DS participan
Externí odkaz:
https://doaj.org/article/0579f0c49bca4a428c6a9aedf4d7f93f
Autor:
Alain D. Dekker, Yannick Vermeiren, Maria Carmona‐Iragui, Bessy Benejam, Laura Videla, Ellen Gelpi, Tony Aerts, Debby Van Dam, Susana Fernández, Alberto Lleó, Sebastian Videla, Anne Sieben, Jean‐Jacques Martin, Netherlands Brain Bank, Rafael Blesa, Juan Fortea, Peter P. De Deyn
Publikováno v:
Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring, Vol 10, Iss 1, Pp 99-111 (2018)
Abstract Introduction People with Down syndrome (DS) are at high risk for Alzheimer's disease (AD). Defects in monoamine neurotransmitter systems are implicated in DS and AD but have not been comprehensively studied in DS. Methods Noradrenaline, adre
Externí odkaz:
https://doaj.org/article/d4ab168ebe3f432eb3c4e7d2baaea7d3
Autor:
Mateus Rozalem Aranha, Maria Florencia Iulita, Victor Montal, Jordi Pegueroles, Alexandre Bejanin, Lídia Vaqué‐Alcázar, Michel J. Grothe, Maria Carmona‐Iragui, Laura Videla, Bessy Benejam, Javier Arranz, Concepción Padilla, Sílvia Valldeneu, Isabel Barroeta, Miren Altuna, Susana Fernández, Laia Ribas, Natalia Valle‐Tamayo, Daniel Alcolea, Sofía González‐Ortiz, Núria Bargalló, Henrik Zetterberg, Kaj Blennow, Rafael Blesa, Thomas Wisniewski, Jorge Busciglio, A. Claudio Cuello, Alberto Lleó, Juan Fortea
Publikováno v:
Alzheimer's & Dementia.